Navigation Links
Instituto Gulbenkian de Ciencia scientist wins new Portuguese award Simbiontes for cancer research
Date:12/15/2010

The Simbiontes ("Symbionts" in English) Project brought together children, their families, artists and scientists in a first of its kind fundraising project in Portugal. A true symbiosis was established between several groups in society, leading to this award for scientific research.

Miguel Godinho Ferreira, group leader at the Instituto Gulbenkian de Cincia, just outside Lisbon, is the first scientist to win the 10,000 euros Simbiontes Award, for his proposal to investigate the cellular changes that cause cancer in adults. Over 80% of cancers appear in adults over 50, making age one of the main risk factors for this disease. Miguel Godinho Ferreira's research promises crucial insights into understanding the causes of cancer, and, potentially, into developing approaches to fight the disease.

Miguel's research interests lie in understanding why the incidence of cancer increases with age. He believes he has a clue as to what may underlie this phenomenon: "Chromosome ends have on them protective structures, made up of DNA, called telomeres. As we age, telomeres become shorter, thus acting like molecular clocks that convey the age of a cell."

Telomeres undergo lifelong wear and tear because the enzyme that builds them is not active in human cells. Indeed, telomerase - as this enzyme is called - is active only in the embryo, and becomes inactive at birth. Miguel and his team are looking for the signals associated to telomerase in young cells, that are absent in old cells. They hope to harness these molecular signals to stop cancer developing in older cells. Says Miguel, "If we could manipulate telomerase so that old cells could be tricked into believing they are younger than they really are, it might just be possible to stop cancer from developing. In this project we will try to prove this hypothesis, using first a model organism (yeast), then extending our findings into human cells, and, potentially, paving the way for new therapies.

Miguel Godinho Ferreira's project was chosen amongst 26 proposals that were submitted to an international panel of cancer research experts. The award marks the endpoint of the first edition of the Simbiontes project, put in place by the Associao Viver a Cincia, in collaboration with the Portuguese Institute of Oncology in Lisbon and the arts school Ar.Co. The aim of the project is to raise funds for research, through the engagement of several groups in society. A series of art workshops were run with children at the Institute of Oncology, based on the book "A Menina do Mar" by Sophia de Mello Breyner. The children made several paintings and drawings, that were auctioned in 2009. Furthermore, an illustrated children's book, titled "Os Amigos da Menina do Mar", by Raquel Gaspar (a biologist) and ngelo Encarnao (an artist), was published. The funds raised from the auction of the paintings and drawings, the sales of the book and other activities make up the Simbiontes award.

Miguel adds, "It is an honour to receive the Simbiontes award, for it's spirit as the public's contribution to scientific research. The value of the award is a small contribution to the project, since scientific research is very expensive, but it will allow us to be bolder in our research".


'/>"/>

Contact: Ana Godinho
agodinho@igc.gulbenkian.pt
351-214-407-959
Instituto Gulbenkian de Ciencia
Source:Eurekalert  

Related medicine news :

1. Scientists Pinpoint Area of Brain That Fears Losing Money
2. Scientists Discover How HIV Is Transmitted Between Men
3. Prevention Is Key Research Goal for Premature Babies, Scientists Say
4. Mensa GLAAM Conference to Feature Christian Drapeau, Stem Cell Author and Scientist
5. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
6. Scientists find donut-shaped structure of enzyme involved in energy metabolism
7. Neuroscientists reveal new links that regulate brain electrical activity
8. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
9. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
10. Scientists Spot Genetic Fingerprints of Individual Cancers
11. AADR awards the 2010 Distinguished Scientist Award to John Greenspan
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Instituto Gulbenkian de Ciencia scientist wins new Portuguese award Simbiontes for cancer research
(Date:1/17/2017)... Chicago, Illinois (PRWEB) , ... January 17, 2017 , ... ... Antonio Breast Cancer Symposium (SABCS) or those who desire a more intimate review and ... Antonio: Breast Cancer – Bench to Bedside—is being offered by Imedex on February 4, ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... Healthful-Flex. , The company, owned and operated by Ed Stroup, was created ... reasonable price with the highest level of customer service. Healthful Balance products can ...
(Date:1/17/2017)... ... , ... Kevin Harrington (one of the original Sharks from mega-hit reality series ... topic of Beauty and Personal Care. , Everyone makes New Year’s ... commit to these changes than beginning with personal care and beauty products? AsSeenOnTV.pro will ...
(Date:1/17/2017)... ... January 17, 2017 , ... Metro Development Group has ... high speed technology into the fabric of an entire community. A highlight of ... and wellness in a yet-to-be-named, health focused campus. Leading this initiative in partnership ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Mirror Mirror ... earned the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, ... part of this elite group of providers. , Produced by Zeltiq, CoolSculpting is ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The global fluoropolymer market in the healthcare industry ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, ... from industry experts. The report covers the market landscape and its ...
(Date:1/17/2017)... --  Tocagen Inc ., a clinical-stage, cancer-selective gene therapy company, today ... and pharmaceutical development at Tocagen, will present at Phacilitate Cell ... in Miami . Details of ... ... viruses - what to do when and why Date and Time: ...
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone) Drug (OTC, Rx), ... report to their offering. ... The global active pharmaceutical ingredients market is expected to ... 2016, growing at a CAGR of 6.3% from 2016 to 2021. ...
Breaking Medicine Technology: